Stella Diagnostics, Inc. (SLDX)
0.0081
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
Stella Diagnostics Debt to Equity Ratio : -0.4877 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4877 |
| March 31, 2026 | -0.1426 |
| December 31, 2025 | -0.4644 |
| September 30, 2025 | -0.1154 |
| June 30, 2025 | -0.1125 |
| March 31, 2025 | -0.3585 |
| December 31, 2024 | -0.3539 |
| September 30, 2024 | -0.3591 |
| June 30, 2024 | -0.3606 |
| March 31, 2024 | -0.3531 |
| December 31, 2023 | -0.3537 |
| September 30, 2023 | -0.3729 |
| June 30, 2023 | -0.3886 |
| March 31, 2023 | -0.3947 |
| December 31, 2022 | -0.3609 |
| September 30, 2022 | -0.9355 |
| June 30, 2022 | -0.0338 |
| March 31, 2022 | -0.0332 |
| September 30, 2021 | -0.1499 |
| June 30, 2021 | -0.1426 |
| March 31, 2021 | -0.1372 |
| September 30, 2020 | -0.01 |
| June 30, 2020 | -0.2486 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.2861 |
| December 31, 2019 | -0.286 |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| March 31, 2018 | -1.785 |
| September 30, 2016 | -2.623 |
| June 30, 2016 | -2.623 |
| March 31, 2016 | -2.680 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | -2.229 |
| March 31, 2015 | -2.450 |
| December 31, 2014 | -2.648 |
| September 30, 2014 | -3.839 |
| June 30, 2014 | -3.879 |
| March 31, 2014 | -3.993 |
| December 31, 2013 | -5.306 |
| September 30, 2013 | -7.686 |
| June 30, 2013 | -5.038 |
| March 31, 2013 | -5.918 |
| June 30, 2012 | -1.291 |
| March 31, 2012 | -1.291 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Exlites Holdings International, Inc. | 0.00 |
| Xcelerate, Inc. | -0.8535 |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | -0.8665 |
| Vivos Therapeutics, Inc. | -3.278 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.1132M |
| Total Liabilities (Quarterly) | 29.06M |
| Shareholders Equity (Quarterly) | -28.94M |
| Current Ratio | 0.0023 |
| Net Debt Paydown Yield | -45.99% |